EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Porphyrins as Novel Therapeutics for HIV: Mechanism, Advances, and Challenges

Vidya Laxmi Jaishi, Arushi Dogra, Bangaluru Srihari, Ritu Gaur iD

AIDS Research and Human Retroviruses · 01.07.2026 · 42 (6-7) · 215-221

DOI: 10.1177/08892229261446362 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift AIDS Research and Human Retroviruses, online erschienen am 21.04.2026. Verfasst von Vidya Laxmi Jaishi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Life Sciences and Biotechnology, South Asian University, New Delhi, India. Hauptthemen laut MEDLINE: Porphyrins, HIV Infections, Anti-HIV Agents, HIV-1. Die Arbeit nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porphyrins, a class of heterocyclic macrocycles, have garnered significant attention for their potential antiviral properties, particularly against human immunodeficiency virus (HIV). This review explores how porphyrins and their derivatives inhibit HIV replication, focusing on their interactions with key viral components, including reverse transcriptase, protease, and integrase. In addition, the review highlights the role of porphyrins in photodynamic therapy (PDT) as a novel approach to targeting HIV-infected cells. Recent studies have demonstrated that metalloporphyrins, in particular, exhibit enhanced antiviral activity due to their unique structural and electronic properties. Despite promising in vitro and preclinical results, challenges such as cytotoxicity, bioavailability, and resistance mechanisms remain unaddressed. This review provides a comprehensive analysis of the current state of research on porphyrins as anti-HIV agents, emphasizing their potential as a therapeutic strategy and identifying key areas for future investigation. The findings underscore the importance of porphyrins in the ongoing search for effective antiviral therapies against HIV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PorphyrinsHIV InfectionsAnti-HIV AgentsHIV-1HumansVirus ReplicationPhotochemotherapy

Stichwörter der Autor:innen

HIVentry inhibitorsmetalloporphyrinsporphyrins

Substanzen

PorphyrinsAnti-HIV Agents

Autor:innen und Institutionen

  • Faculty of Life Sciences and Biotechnology, South Asian University, New Delhi, India.

ORCID-Profile: Ritu Gaur

Zitieren

APA

Jaishi, V. L., Dogra, A., Srihari, B., & Gaur, R. (2026). Porphyrins as Novel Therapeutics for HIV: Mechanism, Advances, and Challenges. AIDS Research and Human Retroviruses, 42(6-7), 215-221. https://doi.org/10.1177/08892229261446362

Vancouver

Jaishi VL, Dogra A, Srihari B, Gaur R. Porphyrins as Novel Therapeutics for HIV: Mechanism, Advances, and Challenges. AIDS Research and Human Retroviruses. 2026;42(6-7):215-221. doi:10.1177/08892229261446362

BibTeX
@article{Jaishi2026,
  author = {Jaishi, Vidya Laxmi and Dogra, Arushi and Srihari, Bangaluru and Gaur, Ritu},
  title = {Porphyrins as Novel Therapeutics for HIV: Mechanism, Advances, and Challenges},
  journal = {AIDS Research and Human Retroviruses},
  year = {2026},
  volume = {42},
  number = {6-7},
  pages = {215--221},
  doi = {10.1177/08892229261446362}
}
Kostenlos starten →